Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 127 of 127 entries
View as:
Phase: N/A
Priority: Normal
Start: 03/02/23
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 04/01/21
End: 02/28/24
Due: 02/28/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of AK129 in Patients With Advanced Malignant Tumors | NCT05645276 | Akeso | user2@example.com | None | 2023-03-02 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |
| A Study of AK104（ an Anti-PD-1 and Anti-CTLA-4 Bispecific Antibody) in Recurrent or Metastatic Cervical Cancer | NCT04868708 | Akeso | user2@example.com | None | 2021-04-01 | 2024-02-28 | 2025-02-28 | - | - | 2025-07-14 |